Linda Ward

Fidaxomicin Preserves the Intestinal Microbiome During and After Treatment of Clostridium difficile Infection (CDI) and Reduces Both Toxin Reexpression and Recurrence of CDI

Thomas Louie, Kristine Cannon, Brendan Byrne et al. · Clinical Infectious Diseases · 2012 · 305 citations · Full text

Life Sciences, Microbiology, Pharmacology +16

Detection and quantification of infectious severe acute respiratory coronavirus-2 in diverse clinical and environmental samples

Yi-Chan Lin, Rebecca J. Malott, Linda Ward et al. · Scientific Reports · 2022 · 73 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +10

Enteric microbiome profiles during a randomized Phase 2 clinical trial of surotomycin versus vancomycin for the treatment of Clostridium difficile infection

Kristine Cannon, Brendan Byrne, Jennifer Happe et al. · Journal of Antimicrobial Chemotherapy · 2017 · 34 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +10

A Novel Assay for Detection of Methicillin-Resistant Staphylococcus aureus Directly From Clinical Samples

Jo‐Ann McClure, John Conly, Osahon Obasuyi et al. · Frontiers in Microbiology · 2020 · 32 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17

Differences of the Fecal Microflora With Clostridium difficile Therapies

Thomas Louie, Brendan Byrne, J.C. Herbert Emery et al. · Clinical Infectious Diseases · 2015 · 26 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14